RightFit Trial Directory

Lung Cancer clinical trials in St Louis, MO

42 recruiting lung cancer studies with a site in St Louis, MO.

All trials in St Louis, MO · All Lung Cancer trials

RecruitingPhase 3NCT03394365

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Sponsor: Pierre Fabre Medicament

St Louis, MO · +39 more sites

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Ballwin, MO · Bolivar, MO · Branson, MO · +1147 more sites

RecruitingPhase 3NCT06498635

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Sponsor: National Cancer Institute (NCI)

Ballwin, MO · Kansas City, MO · St Louis, MO · +278 more sites

RecruitingPhase 3NCT07513376

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Sponsor: Merck Sharp & Dohme LLC

St Louis, MO · +23 more sites

RecruitingPhase 1NCT06465069

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Sponsor: Eli Lilly and Company

St Louis, MO · +22 more sites

RecruitingPhase 1NCT06545331

Study of XB010 in Subjects With Solid Tumors

Sponsor: Exelixis

St Louis, MO · +15 more sites

RecruitingPhase 1 / Phase 2NCT07020221

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Sponsor: Verastem, Inc.

St Louis, MO · +12 more sites

RecruitingPhase 3NCT06712355

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Sponsor: BioNTech SE

St Louis, MO · +35 more sites

RecruitingPhase 1 / Phase 2NCT05786924

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Sponsor: Institut de Recherches Internationales Servier

St Louis, MO · +20 more sites

RecruitingPhase 1NCT07094204

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Sponsor: Astellas Pharma Inc

St Louis, MO · +10 more sites

RecruitingPhase 2NCT06031688

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Cape Girardeau, MO · City of Saint Peters, MO · Creve Coeur, MO · +275 more sites

RecruitingPhase 2 / Phase 3NCT07100080

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Sponsor: Bristol-Myers Squibb

St Louis, MO · +27 more sites

RecruitingPhase 2NCT06449313

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features

Sponsor: Georgetown University

St Louis, MO · +2 more sites

RecruitingPhase 1NCT06270706

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Sponsor: Pliant Therapeutics, Inc.

St Louis, MO · +15 more sites

RecruitingPhase 2NCT07293247

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Sponsor: Alliance for Clinical Trials in Oncology

Cape Girardeau, MO · Farmington, MO · Sainte Genevieve, MO · +108 more sites

RecruitingPhase 2NCT06172478

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Sponsor: Daiichi Sankyo

St Louis, MO · +12 more sites

RecruitingPhase 1NCT06218914

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Sponsor: AstraZeneca

St Louis, MO · +17 more sites

RecruitingPhase 1NCT07037758

A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

Sponsor: Amgen

St Louis, MO · +12 more sites

RecruitingPhase 1NCT06858813

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

Sponsor: AbbVie

St Louis, MO · +9 more sites

RecruitingPhase 1NCT06529822

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Sponsor: Washington University School of Medicine

St Louis, MO · +2 more sites

RecruitingPhase 3NCT06767514

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Sponsor: Summit Therapeutics

Kansas City, MO · St Louis, MO · +94 more sites

RecruitingPhase 2NCT06855771

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

Sponsor: Bristol-Myers Squibb

St Louis, MO · +9 more sites

RecruitingPhase 1 / Phase 2NCT07491497

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

Sponsor: TRIANA Biomedicines, Inc.

St Louis, MO · +13 more sites

RecruitingNot applicableNCT04949464

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

Sponsor: AIDS Malignancy Consortium

St Louis, MO · +10 more sites

RecruitingPhase 3NCT06203210

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Sponsor: Daiichi Sankyo

St Louis, MO · +29 more sites

RecruitingPhase 1NCT06910657

IDOV-Immune for Advanced Solid Tumors

Sponsor: ViroMissile, Inc.

St Louis, MO · +2 more sites

RecruitingPhase 1NCT07545954

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

Sponsor: Washington University School of Medicine

St Louis, MO

RecruitingPhase 3NCT06686771

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Sponsor: Canadian Cancer Trials Group

Cape Girardeau, MO · City of Saint Peters, MO · Creve Coeur, MO · +68 more sites

RecruitingNot applicableNCT07296887

CARE Tool Study Aim 3

Sponsor: Washington University School of Medicine

Rolla, MO · St Louis, MO · +1 more sites

RecruitingPhase not listedNCT07327489

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Sponsor: Elephas

Springfield, MO · St Louis, MO · +5 more sites

RecruitingPhase 1NCT07046923

A Study of LY4175408 in Participants With Advanced Cancer

Sponsor: Eli Lilly and Company

St Louis, MO · +14 more sites

RecruitingPhase 1 / Phase 2NCT06051695

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Sponsor: A2 Biotherapeutics Inc.

St Louis, MO · +11 more sites

RecruitingPhase 2NCT05642572

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Cape Girardeau, MO · City of Saint Peters, MO · Creve Coeur, MO · +451 more sites

RecruitingPhase 2 / Phase 3NCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Sponsor: SWOG Cancer Research Network

Ballwin, MO · Bonne Terre, MO · Cape Girardeau, MO · +1226 more sites

RecruitingPhase 2NCT06769126

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Sponsor: SWOG Cancer Research Network

Kansas City, MO · Lee's Summit, MO · +145 more sites

RecruitingPhase not listedNCT04354064

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Sponsor: Washington University School of Medicine

St Louis, MO

RecruitingPhase 1 / Phase 2NCT07030257

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Sponsor: Tasca Therapeutics

St Louis, MO · +12 more sites

RecruitingPhase not listedNCT05236114

GEMINI-NSCLC: NSCLC Biomarker Study

Sponsor: Tempus AI

Joplin, MO · Osage Beach, MO · Springfield, MO · +55 more sites

RecruitingPhase 1 / Phase 2NCT05490472

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Sponsor: Jacobio Pharmaceuticals Co., Ltd.

St Louis, MO · +3 more sites

RecruitingPhase 1NCT05856981

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Sponsor: Sairopa B.V.

St Louis, MO · +3 more sites

RecruitingNot applicableNCT06671613

Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer

Sponsor: VA Office of Research and Development

St Louis, MO · +3 more sites

RecruitingPhase 1 / Phase 2NCT06682793

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Sponsor: A2 Biotherapeutics Inc.

St Louis, MO · +9 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.